Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...
The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...
Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, explored the intricate management of alopecia areata, ...
A young woman who isn’t expected to live past 50 is hitting out at NDIS funding claiming decisions being made are a “mind ...
Verywell Health on MSN1y
How Psoriasis Is DiagnosedMedically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...
The licensing deal with Biosion involves an experimental treatment for severe asthma and skin disorder known ... It also ...
One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.
There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback